enthusiasm concerning the AVGN patents
Agreed--and I hope it doubles again, it's good
for the sector.
...now if folks lurking here want to take a
little of their gains to support the price
of my pony, I would not complain <g> And I'd probably
have some AVGN if I'd seen a recent article--
but I do not remember seeing anything in PNAS,
or in Science, or in Nature this year--those happen
to be the three I keep an eye on (although I only
subscribe to Nature, as you know Rick). I know I
should keep a better eye on everything via Pubmed,
but I don't want to spend more than an hour a day
or so at this--and it's pretty tough reading for sure.
If somebody can point to impressive Avigen results,
please speak up. Heck, Ariad had the most recent and
dazzling results published this year, so I went with it.
The more I have learned the more I liked...terribly interesting
stuff, even if you only have a modest understanding.
And of course I like playing the regulation angle,
and distancing myself from the vectors still--
folks should check out the Bancboston report on
Ariad and come over to the gene therapy thread.
The more critical eyes, the better. "Biotech is tricky"
--don't I know it. |
